{"id": 768917963701379072, "lang": "en", "text": "RT @4TaxFairness: While Mylan is price gouging its EpiPen, it's also dodging taxes. Read more here -&gt; https://t.co/fIBRzbYtF2 https://t.co/\u2026", "urls": [{"url": "https://t.co/fIBRzbYtF2", "expanded_url": "http://bit.ly/2bjF2vP"}], "user": {"id": 29442313}, "id_str": "768917963701379072", "source": "<a href=\"http://twitter.com\" rel=\"nofollow\">Twitter Web Client</a>", "deleted": false, "hashtags": [], "retrieved": "2018-02-06--15-29-32", "created_at": "Thu Aug 25 21:08:23 +0000 2016", "retweet_count": 633, "user_mentions": [{"id": 583377732, "name": "For Tax Fairness", "screen_name": "4TaxFairness"}], "legacy_imported": true, "retweeted_status": {"id": 768913952768000000, "lang": "en", "text": "While Mylan is price gouging its EpiPen, it's also dodging taxes. Read more here -&gt; https://t.co/fIBRzbYtF2 https://t.co/GYk8Q3JNcL", "urls": [{"url": "https://t.co/fIBRzbYtF2", "expanded_url": "http://bit.ly/2bjF2vP"}], "user": {"id": 583377732}, "media": [{"id": 768913949588729856, "url": "https://t.co/GYk8Q3JNcL", "type": "photo", "sizes": {"large": {"h": 900, "w": 925, "resize": "fit"}, "small": {"h": 662, "w": 680, "resize": "fit"}, "thumb": {"h": 150, "w": 150, "resize": "crop"}, "medium": {"h": 900, "w": 925, "resize": "fit"}}, "media_url": "http://pbs.twimg.com/media/Cqu7KcwUMAAlgLF.jpg", "display_url": "pic.twitter.com/GYk8Q3JNcL", "expanded_url": "https://twitter.com/4TaxFairness/status/768913952768000000/photo/1", "media_url_https": "https://pbs.twimg.com/media/Cqu7KcwUMAAlgLF.jpg"}], "id_str": "768913952768000000", "source": "<a href=\"http://sproutsocial.com\" rel=\"nofollow\">Sprout Social</a>", "hashtags": [], "created_at": "Thu Aug 25 20:52:26 +0000 2016", "retweet_count": 633, "user_mentions": [], "favorite_count": 735}}